Literature DB >> 20093241

Diffuse large B-cell lymphoma in Chinese patients: immunophenotypic and cytogenetic analyses of 124 cases.

Yan Chen1, Tao Han, Javeed Iqbal, Richard Irons, Wing C Chan, Xiongzeng Zhu, Kai Fu.   

Abstract

In diffuse large B-cell lymphoma (DLBCL), BCL2 expression usually correlates with the t(14;18) (q32;q21) in germinal center B-cell (GCB) subtype and with gain/amplification of chromosome 18q21 in the activated B cell-like subtype. Studies have suggested that the GCB subtype is less common in Chinese than in Western populations. We studied 124 Chinese DLBCL cases using immunohistochemical, conventional cytogenetics, and interphase fluorescence in situ hybridization analyses. A cohort of 114 well-characterized DLBCL cases from Western populations was also analyzed for comparison. Lower incidences of the GCB subtype (P = .0001) and the t(14;18) translocation (P = .0001) were present in Chinese cases. However, BCL2 overexpression was more frequent in Chinese compared with Western cases (P = .0054). BCL2 expression was associated with gain of chromosome 18/18q in the Chinese and Western cohorts. More interestingly, BCL2 expression was associated with gain of chromosome 3/3q in Chinese DLBCL cases, whereas this association was less significant in Western cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093241     DOI: 10.1309/AJCP4H6ADGYDZMOA

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy.

Authors:  Sukjoong Oh; Dong Hoe Koo; Cheolwon Suh; Shin Kim; Bong Hee Park; Joon Kang; Jooryung Huh
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

2.  Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Authors:  Rachael Thomas; Eric L Seiser; Alison Motsinger-Reif; Luke Borst; Victor E Valli; Kathryn Kelley; Steven E Suter; David Argyle; Kristine Burgess; Jerold Bell; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Leuk Lymphoma       Date:  2011-03-07

3.  Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.

Authors:  Lindsay M Morton; James R Cerhan; Patricia Hartge; Mohammad A Vasef; Vishala T Neppalli; Yasodha Natkunam; Ahmet Dogan; Bhavana J Dave; Smrati Jain; Ronald Levy; Izidore S Lossos; Wendy Cozen; Scott Davis; Mary Jean Schenk; Matthew J Maurer; Charles F Lynch; Nathaniel Rothman; Nilanjan Chatterjee; Kai Yu; Louis M Staudt; Dennis D Weisenburger; Sophia S Wang
Journal:  Int J Mol Epidemiol Genet       Date:  2011-07-05

4.  Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.

Authors:  Carlo Visco; Alexander Tzankov; Zijun Y Xu-Monette; Roberto N Miranda; Yu Chuan Tai; Yan Li; Wei-min Liu; Emanuele S G d'Amore; Yong Li; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Huan-You Wang; Cherie H Dunphy; Eric D His; X Frank Zhao; William W L Choi; Xiaoying Zhao; J Han van Krieken; Qin Huang; Weiyun Ai; Stacey O'Neill; Maurilio Ponzoni; Andres J M Ferreri; Brad S Kahl; Jane N Winter; Ronald S Go; Stephan Dirnhofer; Miguel A Piris; Michael B Møller; Lin Wu; L Jeffrey Medeiros; Ken H Young
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

5.  Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.

Authors:  Amy A Ayers; Lin Lyu; Kaylin Dance; Kevin C Ward; Christopher R Flowers; Jean L Koff; Lauren E McCullough
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-06-26

6.  Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.

Authors:  Qun-Pei Yang; Wen-Yan Zhang; Jian-Bo Yu; Sha Zhao; Huan Xu; Wei-Ya Wang; Cheng-Feng Bi; Zhuo Zuo; Xiao-Qing Wang; Juan Huang; Lin Dai; Wei-Ping Liu
Journal:  Diagn Pathol       Date:  2011-08-22       Impact factor: 2.644

7.  Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Authors:  An Mt Van Nuffel; Vidula Sukhatme; Pan Pantziarka; Lydie Meheus; Vikas P Sukhatme; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2015-02-24

8.  NonHodgkin's Lymphoma with Peritoneal Localization.

Authors:  E Curakova; M Genadieva-Dimitrova; J Misevski; V Caloska-Ivanova; V Andreevski; B Todorovska; U Isahi; M Trajkovska; P Misevska; N Joksimovic; S Genadieva-Stavric; S Antovic; N Jankulovski
Journal:  Case Rep Gastrointest Med       Date:  2014-03-09

9.  Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases.

Authors:  Yan Chen; Xiao-Fei Sun; Zi-Jun Zhen; Juan Wang; Jia Zhu; Su-Ying Lu; Fei-Fei Sun; Fei Zhang; Peng-Fei Li; Rui-Qing Cai
Journal:  Chin J Cancer       Date:  2013-04-01

10.  Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone.

Authors:  Masashi Ohe; Satoshi Hashino; Atsuo Hattori
Journal:  Korean J Hematol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.